FDA Approves MENTOR MemoryGel BOOST Breast Implant

Approximately 400,000 women undergo breast implant surgeries each year in the United States, and selecting an implant is an important and personal part of the process.

Officials with the FDA have approved the MENTOR MemoryGel BOOST breast implant from Mentor Worldwide LLC based on a recent study showing that patients and surgeons both preferred it over another leading brand.

The implant is approved for women ages 22 and older undergoing breast augmentation and for women of all ages undergoing breast reconstruction. It will be commercially available in early 2022, according to a press release.

Approximately 400,000 women undergo breast implant surgeries each year in the United States, and selecting an implant is an important and personal part of the process. In order to enhance patients’ individualized results, surgeons need a wide range of implant sizes and profiles. Although there are many options available, surgeons cite the need for an implant with increased form stability to help shape the breast while still maintaining a natural feel.

“Our commitment to innovation is driven, first and foremost, by the needs of our customers and patients, and providing them with the highest quality products to achieve their desired outcome,” said Lori Tierney, worldwide president of Mentor Worldwide LLC, in the press release. “With this pivotal addition to our MemoryGel portfolio, we are thrilled to provide a meaningful range of options to meet surgeon objectives and patient preferences, beyond what is currently available in the breast aesthetics market.”

A recent survey found that patients and surgeons both preferred the MENTOR MemoryGel BOOST breast implant because it felt more natural compared to another leading brand. The implant combines the company’s proprietary highly cohesive gel, an innovative implant shell design, and precision fill ratio in order to provide an implant with increased form stability.

“Through science-based design and innovation, we are able to offer both increased form stability and a natural feel in the same product,” said Krasimira Hristov, director of research and development at Mentor Worldwide LLC, in the press release. “The MemoryGel BOOST breast implant is truly a unique innovation that satisfies an unmet need and expands the MemoryGel product line.”

REFERENCE

US FDA Approves New MENTOR MemoryGel BOOST Breast Implant. News release. Johnson & Johnson; January 13, 2022. Accessed January 17, 2022. https://www.jnj.com/u-s-fda-approves-new-mentor-memorygel-boost-breast-implant